Wave 80 Biosciences, Inc. (Wave 80 Biosciences) is a medical device company. The company develops next-generation molecular diagnostics instruments and consumables for hepatitis B, hepatitis C, HIV/AIDS and other human health conditions. Its lead product includes EOSCAPE-HIV, which is a compact-form-factor system for measurement of biomarkers in peripheral blood. Wave 80 Biosciences' product pipeline includes EOSCAPE-HBV DNA, EOSCAPE-HIV RNA PLUS, EOSCAPE-TB, EOSCAPE-TB-DST, EOSCAPE-HBV DNA PLUS, EOSCAPE-HCV RNA and EOSCAPE-STD.The company has expertise in high-sensitivity molecular assay methods, microfluidics, user-centered design, photonics, design for manufacturing, clinical trials design, and compliance with diverse global regulatory regimes. Wave 80 Biosciences is headquartered in San Francisco, California, the US.